| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.07 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.1 | 0.08 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.071 | 0.08 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.08 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |